$FIGS earnings report

FIGS reported third-quarter net revenue growth of 25.7%, net income of $19.3 million, adjusted EBITDA margin of 16.5%, and increased its full-year 2026 outlook. AlphAI read FIGS's Third Quarter 2026 filing as strong. 2 quarters are on record below.

Third Quarter 2026

AlphAI · Earnings readFIGS · Third Quarter 2026 · ended September 30, 2026

FIGS reported third-quarter net revenue growth of 25.7%, net income of $19.3 million, adjusted EBITDA margin of 16.5%, and increased its full-year 2026 outlook.

✓Strong quarter

Revenue growth accelerated across scrubwear, non-scrubwear and international markets, while net income, adjusted EBITDA margin and free cash flow increased materially year over year. The company increased its full-year revenue growth and adjusted EBITDA margin outlooks.

Revenue
$ 236
12.9% y/y
Q3 2026 United States net revenues
$154M
20.8 % y/y
Gross margin · GAAP
69.3%
a decrease of 60 basis points year over year y/y
EPS · GAAP
$ 0.10
Q4 2026 and FY 2026 outlook
Q4 up ~15%; FY up ~23.5%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Q3 2026 net revenuesGAAP$190.7M–25.7 %
Q3 2026 cost of goods soldGAAP58,607––
Q3 2026 gross profitGAAP132,082––
Q3 2026 gross marginGAAP69.3%–a decrease of 60 basis points year over year
Q3 2026 selling expensesGAAP44,391––
Q3 2026 marketing expensesGAAP25,486––
Q3 2026 general and administrative expensesGAAP39,996––
Q3 2026 total operating expensesGAAP$109.9M–13.9%
Q3 2026 operating expenses as a percentage of net revenuesGAAP57.6%––
Q3 2026 net income from operationsGAAP22,209––
Q3 2026 total other income, netGAAP2,349––
Q3 2026 provision for income taxesGAAP5,277––
Q3 2026 net incomeGAAP$19.28M––
Q3 2026 net income marginGAAP10.1 %––
Q3 2026 basic earnings per shareGAAP$ 0.12––
Q3 2026 diluted earnings per shareGAAP$ 0.10––
Q3 2026 adjusted EBITDAnon-GAAP$31.52M–an increase of $12.7 million year over year
Q3 2026 adjusted EBITDA marginnon-GAAP16.5 %–expanded 410 basis points
Active customers as of September 30, 2026other3,179–14.3%
Net revenues per active customer as of September 30, 2026other$ 236–12.9%
Q3 2026 average order valueother$ 126–10.5%
Nine months ended September 30, 2026 net revenuesGAAP$547.2M–27.5 %
Nine months ended September 30, 2026 gross profitGAAP388,235––
Nine months ended September 30, 2026 net incomeGAAP$53.95M––
Nine months ended September 30, 2026 diluted earnings per shareGAAP$ 0.28––
Nine months ended September 30, 2026 adjusted EBITDAnon-GAAP$81.99M––
Nine months ended September 30, 2026 adjusted EBITDA marginnon-GAAP15.0 %––
Nine months ended September 30, 2026 net cash provided by operating activitiesGAAP$100.5M––
Nine months ended September 30, 2026 capital expendituresGAAP(10,719)––
Nine months ended September 30, 2026 free cash flownon-GAAP$89.80M––

Segments

SegmentRevenueq/qy/y
Q3 2026 United States net revenuesNo segment-specific driver was provided.$153.9M–20.8 %
Q3 2026 Rest of the world net revenuesNo segment-specific driver was provided.$36.83M–51.4 %
Q3 2026 Scrubwear net revenuesNo segment-specific driver was provided.$157.5M–24.0 %
Q3 2026 Non-Scrubwear net revenuesNo segment-specific driver was provided.$33.18M–34.6 %
Nine months ended September 30, 2026 United States net revenuesNo segment-specific driver was provided.$444.2M–22.3 %
Nine months ended September 30, 2026 Rest of the world net revenuesNo segment-specific driver was provided.$103.0M–56.4 %
Nine months ended September 30, 2026 Scrubwear net revenuesNo segment-specific driver was provided.$445.4M–25.8 %
Nine months ended September 30, 2026 Non-Scrubwear net revenuesNo segment-specific driver was provided.$101.8M–35.4 %

Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.

Q4 2026 and FY 2026 outlook

  • RevenueQ4 up ~15%; FY up ~23.5%
  • NoteFY 2026 Adjusted EBITDA Margin: Approximately 15.8%

Capital returns

  • Repurchases of Class A Common Stock of (46,647) for the nine months ended September 30, 2026.
  • Repurchases of Class A Common Stock of (2,688) for the nine months ended September 30, 2025.
  • The company stated that it continued to return value to shareholders through its recently expanded share repurchase program.

What drove it

  • Net revenues increased primarily due to an increase in orders and higher average order value.
  • Average order value increased primarily due to higher average unit retail from pricing and favorable product mix, as well as lower discount and return rates.
  • Operating expenses as a percentage of net revenues decreased primarily due to fixed cost leverage across general and administrative, marketing, and selling expenses.
  • Pricing increases and ongoing efficiency efforts partially offset gross-margin pressure.
  • Management cited consistent strength across categories, channels and geographies.

Concerns

  • Gross margin decreased 60 basis points year over year, primarily due to outsized improvements in returns processing in the prior year and higher inventory reserves.
  • The company identified risks around customer demand, consumer spending, global trade policy, supply-chain reliance, international expansion, fulfillment, inventory management, marketing, competition and B2B and retail execution.
  • The company did not provide a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income margin outlook.

What to watch

  • Q4 2026 net revenue growth outlook of up ~15%.
  • FY 2026 net revenue growth outlook of up ~23.5%.
  • FY 2026 adjusted EBITDA margin outlook of approximately 15.8%.
  • Whether gross-margin pressure from inventory reserves and the prior-year returns-processing comparison persists.
  • The pace of active customer growth, net revenues per active customer and average order value.
  • International and non-scrubwear revenue growth, which exceeded U.S. and scrubwear growth in Q3.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 76,470 as of September 30, 2026, compared with $ 81,985 as of December 31, 2025.
  • Short-term investments were 254,696 as of September 30, 2026, compared with 218,863 as of December 31, 2025.
  • Inventory, net was 121,335 as of September 30, 2026, compared with 127,966 as of December 31, 2025.
  • Total assets were $ 617,919 as of September 30, 2026, compared with $ 579,996 as of December 31, 2025.
  • Total liabilities were 166,301 as of September 30, 2026, compared with 142,534 as of December 31, 2025.
  • Net cash used in financing activities was (58,776) for the nine months ended September 30, 2026, compared with (1,370) for the nine months ended September 30, 2025.
  • Cash and cash equivalents, end of period were $ 76,470 for the nine months ended September 30, 2026, compared with $ 46,454 for the nine months ended September 30, 2025.

Analysis

FIGS delivered $ 190,689 of Q3 2026 net revenues, up 25.7 % from $ 151,661 in the prior-year quarter. Growth was broad based: scrubwear revenue increased 24.0 %, non-scrubwear increased 34.6 %, U.S. revenue increased 20.8 %, and Rest of the world revenue increased 51.4 %. Management attributed the overall revenue increase primarily to increased orders and higher average order value. Active customers increased 14.3% to 3,179, while net revenues per active customer increased 12.9% to $ 236 and average order value increased 10.5% to $ 126.

Profitability strengthened despite a gross-margin headwind. Gross margin was 69.3%, a decrease of 60 basis points year over year, which the company attributed to outsized improvements in returns processing in the prior year and higher inventory reserves. Pricing increases and ongoing efficiency efforts were partial offsets. Total operating expenses increased 13.9% to $ 109,873, but declined to 57.6% of net revenues from 63.6% in the prior-year period because of fixed-cost leverage across general and administrative, marketing and selling expenses.

The resulting earnings leverage was substantial. Net income rose to $ 19,281 from $ 8,746, diluted earnings per share were $ 0.10 versus $ 0.05, and net income margin reached 10.1 % versus 5.8 %. Adjusted EBITDA increased to $ 31,518 from $ 18,851, with adjusted EBITDA margin expanding to 16.5 % from 12.4 %. For the nine months ended September 30, 2026, net revenues were $ 547,210, net income was $ 53,948, and adjusted EBITDA was $ 81,986.

Cash generation also improved. Net cash provided by operating activities for the nine months ended September 30, 2026 was $ 100,522, compared with $ 242 in the prior-year period, while free cash flow was $ 89,803 compared with $ (5,063). The company reported $ 76,470 of cash and cash equivalents and 254,696 of short-term investments as of September 30, 2026. It used (46,647) for repurchases of Class A Common Stock during the nine-month period.

Management increased its outlook, guiding to Q4 net revenue growth of up ~15%, FY 2026 net revenue growth of up ~23.5%, and FY 2026 adjusted EBITDA margin of approximately 15.8%. The key issues for the remainder of the year are execution against that Q4 growth outlook, the durability of customer and order-value gains, the continuation of international and non-scrubwear growth, and the degree to which inventory reserves and returns-processing comparisons continue to affect gross margin.

Management, verbatim

Our momentum continued in Q3, which marked our fourth straight quarter of greater than 25% net revenues growth, powered by consistent strength across our categories, channels and geographies.

Trina Spear, Chief Executive Officer and Co-Founder

Our adjusted EBITDA margin expanded 410 basis points to 16.5%, further demonstrating the power of our model and the ability to drive leverage across our expense lines.

Sarah Oughtred, Chief Financial Officer

The overall strength of these results, together with our increased conviction in Q4, leads us to raise our full year net revenues and adjusted EBITDA margin outlooks.

Sarah Oughtred, Chief Financial Officer

Not in the filing

stated, not guessed
  • Previous-quarter values and sequential comparisons for Q3 2026 revenue, earnings, margins, operating metrics and segments.
  • Q3 2026 operating cash flow, capital expenditures and free cash flow.
  • A separately reported debt balance as of September 30, 2026.
  • Quantitative gross-margin, operating-expense or tax-rate guidance.
  • Quantitative GAAP net income margin guidance or a reconciliation from FY 2026 adjusted EBITDA margin outlook to GAAP net income margin outlook.
  • Prior outlook figures for comparison with actual results and current guidance.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Second Quarter 2026

AlphAI · Earnings readFIGS · Second Quarter 2026 · ended June 30, 2026

FIGS Releases Second Quarter 2026 Financial Results Exceeded Top and Bottom Line Expectations Grew Net Revenues 28.8% Achieved Net Income Margin of 14.4% and Adjusted EBITDA Margin of 18.6% Increasing Share Repurchase Authorization by $100 Million Increasing Full Year 2026 Outlook

✓Strong quarter

Net revenues grew 28.8% year over year, with growth across scrubwear, non-scrubwear, U.S. and international revenue. Gross margin increased 820 basis points, net income rose to $28.4 million from $7.1 million, and adjusted EBITDA margin reached 18.6%.

Revenue
$197M
28.8% y/y
Scrubwear net revenues
$161M
26.5% year over year y/y
Gross margin · GAAP
75.2%
an increase of 820 basis points year over year y/y
EPS · GAAP
$0.15 in diluted earnings
Full Year 2026 outlook
growth vs. 2025 up approximately 20%

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Net revenuesGAAP$196.6M–28.8%
Gross marginGAAP75.2%–an increase of 820 basis points year over year
Operating expensesGAAP$112.6M–21.9%
Operating expenses as a percentage of net revenuesGAAP57.3%––
Net incomeGAAP$28.4M––
Diluted earnings per shareGAAP$0.15 in diluted earnings per share––
Net income marginGAAP14.4%––
Adjusted EBITDAnon-GAAP$36.6M–an increase of $16.9 million year over year
Adjusted EBITDA marginnon-GAAP18.6%––
Refunds recognized for IEEPA tariffs incurred on goods sold in the prior fiscal yearother$7.9M––
Active customers as of June 30, 2026other3.1M–13.2% year over year
Net revenues per active customerother$229–10.1% year over year
AOVother$127–8.5% year over year

Segments

SegmentRevenueq/qy/y
Scrubwear net revenuesNot specified in the provided filing text.$161.2M–26.5% year over year
Non-scrubwear net revenuesNot specified in the provided filing text.$35.4M–40.3% year over year
U.S. net revenuesNot specified in the provided filing text.$158.7M–22.2% year over year
International net revenuesNot specified in the provided filing text.$37.9M–67.0% year over year

Full Year 2026 outlook

  • Revenuegrowth vs. 2025 up approximately 20%
  • NoteAdjusted EBITDA Margin (2)(4) 14.8% to 15.0%

Capital returns

  • As of June 30, 2026, the Company had approximately $19.2 million available for future repurchases under the Company’s ongoing share repurchase program for its outstanding Class A common stock.
  • On August 6, 2026, the Company’s Board of Directors authorized a $100.0 million increase to the share repurchase program.
  • The share repurchase program has no expiration date.

What drove it

  • Net revenue growth was primarily due to an increase in orders and higher average order value (“AOV”).
  • AOV increased primarily driven by higher average unit retail due to pricing and favorable product mix.
  • Gross margin expansion was primarily due to a 780 basis point positive impact from IEEPA tariff refunds recognized, favorable impacts from pricing and ongoing efficiency efforts.
  • Operating expenses as a percentage of net revenues decreased primarily due to fixed cost leverage and lower stock-based compensation expense.

Concerns

  • Higher tariffs partially offset favorable impacts on gross margin.
  • Adjusted EBITDA excludes $7.9 million in refunds recognized for IEEPA tariffs incurred on goods sold in the prior fiscal year.
  • The Company has not provided a quantitative reconciliation of its adjusted EBITDA margin outlook to a GAAP net income margin outlook.

What to watch

  • Delivery of full year 2026 net revenues growth vs. 2025 of up approximately 20%.
  • Delivery of full year 2026 Adjusted EBITDA Margin of 14.8% to 15.0%.
  • Sustainability of international net revenue growth and non-scrubwear net revenue growth.
  • The effects of tariffs, pricing, product mix and ongoing efficiency efforts on gross margin.

Analysis

FIGS reported $196.6 million of net revenues in the second quarter of 2026, up 28.8% year over year. Growth was broad-based in the reported revenue categories and geographies: scrubwear net revenues increased 26.5%, non-scrubwear net revenues increased 40.3%, U.S. net revenues increased 22.2%, and international net revenues increased 67.0%. Management attributed total revenue growth primarily to increased orders and higher AOV.

Customer and order metrics point to both a larger active base and higher revenue per customer. Active customers as of June 30, 2026 increased 13.2% year over year to 3.1 million, net revenues per active customer increased 10.1% to $229, and AOV increased 8.5% to $127. The stated AOV drivers were higher average unit retail from pricing and favorable product mix.

Profitability improved materially. Gross margin was 75.2%, an increase of 820 basis points year over year, with a 780 basis point positive impact from IEEPA tariff refunds recognized, alongside favorable pricing and efficiency effects. Higher tariffs partly offset those benefits. Operating expenses rose 21.9% to $112.6 million, but declined as a percentage of net revenues to 57.3% from 60.5%, reflecting fixed-cost leverage and lower stock-based compensation expense. Net income was $28.4 million, or $0.15 in diluted earnings per share, compared with $7.1 million, or $0.04 in diluted earnings per share, in the same period last year.

Adjusted EBITDA was $36.6 million, an increase of $16.9 million year over year, and adjusted EBITDA margin was 18.6% versus 12.9% in the same period last year. The adjusted result excludes $7.9 million of refunds recognized for IEEPA tariffs incurred on goods sold in the prior fiscal year, while the gross-margin discussion identifies tariff refunds as a major reported gross-margin benefit. This distinction is important when assessing the underlying operating-margin improvement.

For full year 2026, FIGS guided to net revenues growth versus 2025 of up approximately 20% and Adjusted EBITDA Margin of 14.8% to 15.0%. The company also increased its share repurchase authorization by $100.0 million on August 6, 2026, after having approximately $19.2 million available for future repurchases as of June 30, 2026. The filing does not provide the prior outlook, so the magnitude of the outlook increase cannot be assessed from the provided documents.

Management, verbatim

FIGS’ exceptional Q2 performance was powered by strong, ongoing traction across the business, with outperformance on both the top and bottom lines.

Trina Spear, Chief Executive Officer and Co-Founder

We are once again demonstrating the power of our business model to combine growth and profitability.

Sarah Oughtred, Chief Financial Officer

Not in the filing

stated, not guessed
  • Prior-quarter revenue, margin, earnings, EPS, segment, operating-metric and cash-flow comparisons.
  • Reported prior-year dollar amount for net revenues.
  • Reported prior-year gross margin percentage.
  • GAAP operating income or loss.
  • Operating cash flow, capital expenditures and free cash flow figures.
  • Cash, cash equivalents, marketable securities, debt and other balance-sheet figures.
  • Share repurchases executed during the period, share count repurchased and dividend information.
  • Prior full year 2026 outlook needed to compare actual results with prior guidance and quantify the outlook change.
  • Guidance for gross margin, operating expenses and tax rate.
  • Detailed financial statements, GAAP-to-non-GAAP reconciliation tables and key operating metric tables are not included in the provided filing text.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about FIGS earnings dates

When is FIGS's next earnings date?
AlphAI has no date for FIGS yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.